JADE BIOSCIENCES INC COM NEW

$JBIO
Smart money positioned

10 of the Top-200 alpha managers hold $JBIO as of the latest 13F snapshot.

13F holders
112
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

10 holders · Q1 2026

$JBIO is held by 10 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 1.17%, with an average of 0.26% of portfolio. Largest holder: Bellevue Group AG at 1.17%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 112 · Source: 13F-HR
01
Rokos Capital Management LLP
1.17% of portfolio
3,501,502 sh
02
Fairmount Funds Management LLC
2.50% of portfolio
3,220,368 sh
03
Bienville Capital Management, LLC
1.69% of portfolio
3,220,364 sh
04
VR Adviser, LLC
1.76% of portfolio
3,220,364 sh
05
Thomas H Lee Partners LP
0.02% of portfolio
3,105,669 sh
06
KGH Ltd
15.55% of portfolio
3,051,640 sh
07
Wynnefield Capital Inc.
0.13% of portfolio
1,641,137 sh
08
Remedium Capital Partners, LLC
8.08% of portfolio
1,577,750 sh
09
WT Asset Management Ltd
7.73% of portfolio
1,400,708 sh
10
Castleview Partners, LLC
1.32% of portfolio
968,798 sh
See all 112 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $JBIO in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $JBIO in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:40 UTC.